Correlation Between Immunoprecise Antibodies and Berkeley Lights

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immunoprecise Antibodies and Berkeley Lights at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunoprecise Antibodies and Berkeley Lights into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunoprecise Antibodies and Berkeley Lights, you can compare the effects of market volatilities on Immunoprecise Antibodies and Berkeley Lights and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunoprecise Antibodies with a short position of Berkeley Lights. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunoprecise Antibodies and Berkeley Lights.

Diversification Opportunities for Immunoprecise Antibodies and Berkeley Lights

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Immunoprecise and Berkeley is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Immunoprecise Antibodies and Berkeley Lights in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Berkeley Lights and Immunoprecise Antibodies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunoprecise Antibodies are associated (or correlated) with Berkeley Lights. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Berkeley Lights has no effect on the direction of Immunoprecise Antibodies i.e., Immunoprecise Antibodies and Berkeley Lights go up and down completely randomly.

Pair Corralation between Immunoprecise Antibodies and Berkeley Lights

Considering the 90-day investment horizon Immunoprecise Antibodies is expected to generate 1.51 times more return on investment than Berkeley Lights. However, Immunoprecise Antibodies is 1.51 times more volatile than Berkeley Lights. It trades about 0.01 of its potential returns per unit of risk. Berkeley Lights is currently generating about -0.09 per unit of risk. If you would invest  720.00  in Immunoprecise Antibodies on April 5, 2022 and sell it today you would lose (336.00)  from holding Immunoprecise Antibodies or give up 46.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Immunoprecise Antibodies  vs.  Berkeley Lights

 Performance (%) 
      Timeline 
Immunoprecise Antibodies 
Immunoprecise Performance
0 of 100
Over the last 90 days Immunoprecise Antibodies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite sluggish performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in August 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Structure and Payout Changes

Last Split Factor
1:5
Dividend Date
2020-11-23
Last Split Date
2020-11-23

Immunoprecise Price Channel

Berkeley Lights 
Berkeley Performance
0 of 100
Over the last 90 days Berkeley Lights has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Berkeley Lights is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Berkeley Price Channel

Immunoprecise Antibodies and Berkeley Lights Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with Immunoprecise Antibodies and Berkeley Lights

The main advantage of trading using opposite Immunoprecise Antibodies and Berkeley Lights positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunoprecise Antibodies position performs unexpectedly, Berkeley Lights can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Berkeley Lights will offset losses from the drop in Berkeley Lights' long position.

Immunoprecise Antibodies

Pair trading matchups for Immunoprecise Antibodies

The idea behind Immunoprecise Antibodies and Berkeley Lights pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Berkeley Lights

Pair trading matchups for Berkeley Lights

Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go